Tech Company Financing Transactions

Sequella Funding Round

On 2/22/2010, Sequella received $2 million in investment from private investors.

Transaction Overview

Company Name
Announced On
2/22/2010
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9610 Medical Center Dr. 200
Rockville, MD 20850
USA
Email Address
Overview
Sequella develops products to improve diagnosis and treatment of infectious diseases that pose serious risk to public health and have both significant market opportunities and clear commercialization pathways.
Profile
Sequella LinkedIn Company Profile
Social Media
Sequella Company Twitter Account
Company News
Sequella News
Facebook
Sequella on Facebook
YouTube
Sequella on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Carol Nacy
  Carol Nacy LinkedIn Profile  Carol Nacy Twitter Account  Carol Nacy News  Carol Nacy on Facebook
Chief Scientific Officer
Leo Einck
  Leo Einck LinkedIn Profile  Leo Einck Twitter Account  Leo Einck News  Leo Einck on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/22/2010: IntelliOne Technology venture capital transaction
Next: 2/22/2010: Pulmonx venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary